SSR2 and hepatocellular carcinoma: In order to further explore if SNHG14 promoted HCC progression by targeting miR-876-5p/SSR2 axis, we first checked whether SNHG14 regulated the expression of SSR2 independent of miR-876-5p through RIP analysis.